Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
Naimi A, Mohammed RN, Raji A, Chupradit S, Yumashev AV, Suksatan W, Shalaby MN, Thangavelu L, Kamrava S, Shomali N, Sohrabi AD, Adili A, Noroozi-Aghideh A, Razeghian E. Naimi A, et al. Among authors: thangavelu l. Cell Commun Signal. 2022 Apr 7;20(1):44. doi: 10.1186/s12964-022-00854-y. Cell Commun Signal. 2022. PMID: 35392976 Free PMC article. Review.
The role of non-coding genome in the behavior of infiltrated myeloid-derived suppressor cells in tumor microenvironment; a perspective and state-of-the-art in cancer targeted therapy.
Shabgah AG, Salmaninejad A, Thangavelu L, Alexander M, Yumashev AV, Goleij P, Hedayati-Moghadam M, Mohammadi H, Ahmadi M, Navashenaq JG. Shabgah AG, et al. Among authors: thangavelu l. Prog Biophys Mol Biol. 2021 May;161:17-26. doi: 10.1016/j.pbiomolbio.2020.11.006. Epub 2020 Nov 28. Prog Biophys Mol Biol. 2021. PMID: 33259833 Review.
CAR T cells in solid tumors: challenges and opportunities.
Marofi F, Motavalli R, Safonov VA, Thangavelu L, Yumashev AV, Alexander M, Shomali N, Chartrand MS, Pathak Y, Jarahian M, Izadi S, Hassanzadeh A, Shirafkan N, Tahmasebi S, Khiavi FM. Marofi F, et al. Among authors: thangavelu l. Stem Cell Res Ther. 2021 Jan 25;12(1):81. doi: 10.1186/s13287-020-02128-1. Stem Cell Res Ther. 2021. PMID: 33494834 Free PMC article. Review.
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.
Marofi F, Rahman HS, Thangavelu L, Dorofeev A, Bayas-Morejón F, Shirafkan N, Shomali N, Chartrand MS, Jarahian M, Vahedi G, Mohammed RN, Shahrokh S, Akbari M, Khiavi FM. Marofi F, et al. Among authors: thangavelu l. Stem Cell Res Ther. 2021 Mar 22;12(1):200. doi: 10.1186/s13287-021-02251-7. Stem Cell Res Ther. 2021. PMID: 33752707 Free PMC article. Review.
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies.
Marofi F, Saleh MM, Rahman HS, Suksatan W, Al-Gazally ME, Abdelbasset WK, Thangavelu L, Yumashev AV, Hassanzadeh A, Yazdanifar M, Motavalli R, Pathak Y, Naimi A, Baradaran B, Nikoo M, Khiavi FM. Marofi F, et al. Among authors: thangavelu l. Stem Cell Res Ther. 2021 Jul 2;12(1):374. doi: 10.1186/s13287-021-02462-y. Stem Cell Res Ther. 2021. PMID: 34215336 Free PMC article. Review.
A comprehensive review of IL-26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections.
Gowhari Shabgah A, Abdelbasset WK, Sulaiman Rahman H, Bokov DO, Suksatan W, Thangavelu L, Ahmadi M, Malekahmadi M, Gheibihayat SM, Gholizadeh Navashenaq J. Gowhari Shabgah A, et al. Among authors: thangavelu l. Immunology. 2022 Jan;165(1):44-60. doi: 10.1111/imm.13424. Epub 2021 Nov 8. Immunology. 2022. PMID: 34716913 Free article. Review.
Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements.
Rahbaran M, Razeghian E, Maashi MS, Jalil AT, Widjaja G, Thangavelu L, Kuznetsova MY, Nasirmoghadas P, Heidari F, Marofi F, Jarahian M. Rahbaran M, et al. Among authors: thangavelu l. Stem Cells Int. 2021 Nov 30;2021:2347506. doi: 10.1155/2021/2347506. eCollection 2021. Stem Cells Int. 2021. PMID: 34887927 Free PMC article. Review.
Does CCL19 act as a double-edged sword in cancer development?
Gowhari Shabgah A, Al-Obaidi ZMJ, Sulaiman Rahman H, Kamal Abdelbasset W, Suksatan W, Bokov DO, Thangavelu L, Turki Jalil A, Jadidi-Niaragh F, Mohammadi H, Mashayekhi K, Gholizadeh Navashenaq J. Gowhari Shabgah A, et al. Among authors: thangavelu l. Clin Exp Immunol. 2022 Apr 4;207(2):164-175. doi: 10.1093/cei/uxab039. Clin Exp Immunol. 2022. PMID: 35020885 Free PMC article. Review.
103 results